Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins

Lignende værker

• Endogenous T-cell receptor promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated T-cell receptor knockout CAR
  af: Stenger, Dana, et al.
  Udgivet: (2020)
• Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
  af: Kaeuferle, Theresa, et al.
  Udgivet: (2019)
• CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation
  af: Kaeuferle, Theresa, et al.
  Udgivet: (2020)
• PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
  af: Rataj, Felicitas, et al.
  Udgivet: (2018)
• Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells
  af: Willier, Semjon, et al.
  Udgivet: (2020)